5 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... ivermectin… #COVID19 ... SARS-CoV-2 #Pandemic #Outbreak ... EmergencyMedicine #Pharmacology ... Virus #Antiviral #Management
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... investigated for COVID ... CoronaVirus #Treatment #Management ... #Pandemic #Outbreak ... Pharmacotherapy #Pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... Cytokine Activation Syndrome ... correlate with severe COVID ... #Pharmacology # ... Management #Medications
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... flaccid weakness Epidemiology ... like illnesses, COVID ... Miller Fisher Syndrome ... #diagnosis #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Sjogren's Syndrome ... Overview Epidemiology ... SLE • Mikulicz syndrome ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management